SHERRY KELLY: Open Payments
NPI 1558535237 · HAZARD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$378 in 19 payments from 9 companies in 2025. Trend: 2023 $421 · 2024 $227 · 2025 $378
Food & beverage: $378
| Company | Payments | Amount |
|---|---|---|
| Lundbeck LLC | 4 | $70 |
| Vanda Pharmaceuticals Inc. | 2 | $62 |
| Janssen Pharmaceuticals, Inc | 3 | $59 |
| ABBVIE INC. | 3 | $57 |
| Teva Pharmaceuticals USA, Inc. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| SANOFI-AVENTIS U.S. LLC | 1 | $18 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
Products named: REXULTI, HETLIOZ, VRAYLAR, UZEDY, INVEGA SUSTENNA, COBENFY, Auvelity, SPRAVATO.
Industry payments across KY — which companies pay providers there.
